PURPOSE: Multicentre data are limited to appraise the management and prognosis of critically ill human immunodeficiency virus (HIV)-infected patients. We sought to describe temporal trends in demographic and clinical characteristics, indications for intensive care and outcome in this patient population. METHODS: We conducted a cohort study of unselected HIV-infected patients admitted between 1999 and 2010 to 34 French ICUs contributing to the CUB-Réa prospective database. RESULTS: We included 6,373 consecutive patients. Over the 12-year period, increases occurred in median age (39 years in 1999-2001; 47 years in 2008-2010, p < 0.0001) and prevalence of comorbidities (notably malignancies, from 6.7 to 16.4%, p < 0.0001). Admissions for respiratory failure (39.8% overall), shock (8.1%) and coma (22.7%) decreased (p < 0.0001), while those for sepsis (19.3%) remained stable. The main final diagnoses were bacterial sepsis (24.6%) and non-bacterial acquired immune deficiency syndrome (AIDS)-defining diseases (steady decline from 26.0 to 17.5%, p < 0.0001). Patients increasingly received mechanical ventilation (from 42.9 to 54.0%) and renal replacement therapy (from 9.6 to 16.8%) (p < 0.0001), whereas vasopressor use remained stable (27.4%). ICU readmissions increased after 2004 (p < 0.0001). ICU and hospital mortality (17.6 and 26.9%, respectively) dropped markedly in the most severely ill patients requiring multiple life-sustaining therapies. Malignancies and chronic liver disease were heavily associated with hospital mortality by multivariate analysis, while the most common AIDS-defining complications (Pneumocystis jirovecii pneumonia, cerebral toxoplasmosis and tuberculosis) had no independent impact. CONCLUSIONS: Progressive ageing, increasing prevalence of comorbidities (mainly malignancies), a steady decline in AIDS-related illnesses and improved benefits from life-sustaining therapies were the main temporal trends in HIV-infected patients requiring ICU admission.
PURPOSE: Multicentre data are limited to appraise the management and prognosis of critically ill human immunodeficiency virus (HIV)-infectedpatients. We sought to describe temporal trends in demographic and clinical characteristics, indications for intensive care and outcome in this patient population. METHODS: We conducted a cohort study of unselected HIV-infectedpatients admitted between 1999 and 2010 to 34 French ICUs contributing to the CUB-Réa prospective database. RESULTS: We included 6,373 consecutive patients. Over the 12-year period, increases occurred in median age (39 years in 1999-2001; 47 years in 2008-2010, p < 0.0001) and prevalence of comorbidities (notably malignancies, from 6.7 to 16.4%, p < 0.0001). Admissions for respiratory failure (39.8% overall), shock (8.1%) and coma (22.7%) decreased (p < 0.0001), while those for sepsis (19.3%) remained stable. The main final diagnoses were bacterial sepsis (24.6%) and non-bacterial acquired immune deficiency syndrome (AIDS)-defining diseases (steady decline from 26.0 to 17.5%, p < 0.0001). Patients increasingly received mechanical ventilation (from 42.9 to 54.0%) and renal replacement therapy (from 9.6 to 16.8%) (p < 0.0001), whereas vasopressor use remained stable (27.4%). ICU readmissions increased after 2004 (p < 0.0001). ICU and hospital mortality (17.6 and 26.9%, respectively) dropped markedly in the most severely ill patients requiring multiple life-sustaining therapies. Malignancies and chronic liver disease were heavily associated with hospital mortality by multivariate analysis, while the most common AIDS-defining complications (Pneumocystis jirovecii pneumonia, cerebral toxoplasmosis and tuberculosis) had no independent impact. CONCLUSIONS: Progressive ageing, increasing prevalence of comorbidities (mainly malignancies), a steady decline in AIDS-related illnesses and improved benefits from life-sustaining therapies were the main temporal trends in HIV-infectedpatients requiring ICU admission.
Authors: Azure T Makadzange; Chiratidzo E Ndhlovu; Kudakwashe Takarinda; Michael Reid; Magna Kurangwa; Philimon Gona; James G Hakim Journal: Clin Infect Dis Date: 2010-06-01 Impact factor: 9.079
Authors: Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Kathleen M Akgün; Kirsha Gordon; Margaret Pisani; Terri Fried; Kathleen A McGinnis; Janet P Tate; Adeel A Butt; Cynthia L Gibert; Laurence Huang; Maria C Rodriguez-Barradas; David Rimland; Amy C Justice; Kristina Crothers Journal: J Acquir Immune Defic Syndr Date: 2013-01-01 Impact factor: 3.731
Authors: Alison Morris; Jennifer Creasman; Joan Turner; John M Luce; Robert M Wachter; Laurence Huang Journal: Am J Respir Crit Care Med Date: 2002-08-01 Impact factor: 21.405
Authors: Andrew Zolopa; Janet Andersen; William Powderly; Alejandro Sanchez; Ian Sanne; Carol Suckow; Evelyn Hogg; Lauren Komarow Journal: PLoS One Date: 2009-05-18 Impact factor: 3.240
Authors: Matthieu Schmidt; Peter Schellongowski; Nicolò Patroniti; Fabio Silvio Taccone; Dinis Reis Miranda; Jean Reuter; Helène Prodanovic; Marc Pierrot; Amandine Dorget; Sunghoon Park; Martin Balik; Alexandre Demoule; Ilaria Alice Crippa; Alain Mercat; Philipp Wohlfarth; Romain Sonneville; Alain Combes Journal: Am J Respir Crit Care Med Date: 2018-05-15 Impact factor: 21.405
Authors: Samuel M Brown; Emily Wilson; Angela P Presson; Chong Zhang; Victor D Dinglas; Tom Greene; Ramona O Hopkins; Dale M Needham Journal: Thorax Date: 2016-07-20 Impact factor: 9.139
Authors: Maryse A Wiewel; Michaëla A Huson; Lonneke A van Vught; Arie J Hoogendijk; Peter M C Klein Klouwenberg; Janneke Horn; René Lutter; Olaf L Cremer; Marcus J Schultz; Marc J Bonten; Tom van der Poll Journal: Crit Care Date: 2016-10-10 Impact factor: 9.097
Authors: Arthur Kwizera; Mary Nabukenya; Agaba Peter; Lameck Semogerere; Emmanuel Ayebale; Catherine Katabira; Samuel Kizito; Cecilia Nantume; Ian Clarke; Jane Nakibuuka Journal: Crit Care Res Pract Date: 2016-10-09
Authors: François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay Journal: Intensive Care Med Date: 2020-02-03 Impact factor: 17.440
Authors: Kathleen M Akgün; Supriya Krishnan; Adeel A Butt; Cynthia L Gibert; Christopher J Graber; Laurence Huang; Margaret A Pisani; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Amy C Justice; Kristina Crothers; Janet P Tate Journal: AIDS Date: 2021-11-15 Impact factor: 4.177
Authors: Jonathan Rilinger; Viviane Zotzmann; Xavier Bemtgen; Siegbert Rieg; Paul M Biever; Daniel Duerschmied; Torben Pottgiesser; Klaus Kaier; Christoph Bode; Dawid L Staudacher; Tobias Wengenmayer Journal: Artif Organs Date: 2021-05-04 Impact factor: 2.663